The first out of 20 reasons of lack of transparency in Public Administrations is the practice of his position without the appointment has been published in the Official Diary of the corresponding country.

One example of that is the case of Margarita Arboix as assistant director of medicines for veterinarian use of the Spanish agency of medicine within 2000-2006.
On October 10th 2000 it was released a notice which announced that Ismael Diaz Yubero had been ceased of his position as assistant director of medicines for veterinarian use. On the Official State Bulletin it was announced the vacant position on November 13th 2000. We have also found the announcement on January 25th 2006 where they inform that Consuelo Rubio Montejano would occupy the position of Assistant Director which was published on February 1st 2006.

Therefore we can see that from November 13th 2000 to January 1st 2006 somebody has practised this position without being published in any Official State Bulletin. For this reason we contacted by email the current Assistant Direction of medicines for veterinarian use on August 25th 2010 to ask for further information.
This application of information has been read twice (August 26th and September 9th 2010) but so far (September 12th 2010) it has not been answered.
The article 9.3 of the own Spanish Constitution guarantees the publicity of the rules, despite of existing another law since 1886 and lately the rule RD 181/2008 which state the Official State Bulletin is the channel to publish laws, rules and so on. Among them we can find the Section II “Authorities and personnel” and the subsection A “Appointments, situations and incidences”.
As far as we are aware, Margarita Arboix Arzo practised the position of Assistant Director of the Medicines of veterinarian use for the Spanish agency of the medicine, between 2000 and 2006, without being published her appointment in the Official State Bulletin.

Apart from this irregularity we have seen that several complaints about corruption in the Assistant direction of the medicine for veterinarian use of the Spanish agency of the medicine have been reported during this period (2000-2006) to several law institutions.

The lack of response at our application against the Spanish agency of the medicine, it does increase our suspicions that actions presumably corruptive are real and permit us to formulate the following questions:

-Who appointed Margarita Arboix in such a responsible position?
-What was the aim of her appointment?
-Are the documents and agreements signed during her period legal?
-Is there any connection between these agreements and the personal interests that Margarita Arboix had with the veterinarian industry?
-Who has obtained benefits of the agreements achieved by the Assistant Direction during the period she works there?

We are afraid that the answer of these questions can be found in the content of the reports we referred before.

From Veterinaria Digital we are at the disposal of those people who can supply further information about these incidences and we announce that in the following chapters of transparency we will publish documents to provide further information.